CODX vs SRE · rev $3.9M vs P/E 31, rev $13.70B
Co-Diagnostics, Inc. Common Stock (CODX) versus Sempra Energy (SRE) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
CODX currently screens at market cap $31.4M. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Not investment advice. Open the CODX and SRE stock pages for the full models.
Not investment advice.